American Association for Clinical Chemistry
Better health through laboratory medicine
2002 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

10/15/02 AACC wrote to CMS recommending that CMS develop a formal process for reconsidering inappropriately reimbursed gap-filled codes
   
09/30/02 AACC wrote to CMS supporting its 2003 new code payment recommendations
   
08/26/02 AACC wrote to HHS Secretary Tommy Thompson regarding efforts to waive rapid HIV tests under CLIA'88.
   
08/26/02 AACC wrote to CMS requesting that pharmacies performing laboratory testing be included among those certificate of waiver laboratories inspected by the agency.
   
08/05/02 AACC submitted comments to CMS suggesting payment rates for new CPT codes.
   
07/26/02 AACC submitted comments to the FDA regarding its June 20, 2002 advance notice of proposed rulemaking regarding needlestick injuries
   
07/05/02 AACC wrote to Representative Nancy Johnson (R-CT) endorsing H.R.4889, the Patient Safety Improvement Act of 2002.
   
06/25/02 AACC wrote to Representative Billy Tauzin endorsing H.R. 4954, the Medicare Modernization and Prescription Drug Act of 2002.
   
06/21/02 AACC's statement submitted to PACHA regarding the waiver of rapid HIV tests
   
06/19/02 AACC submitted comments to the FDA regarding the classification of HIV genotyping assays
 
05/20/02 AACC wrote to key House members opposing proposed cuts in laboratory reimbursement
 
04/16/02 AACC submitted comments to HHS regardings its March 27, 2002 proposed changes to the medical privacy rule.
 
04/10/02 AACC submitted comments to SACGT regarding proposed genetic testing brochure.
 
03/15/02 AACC wrote to key House and Senate appropriators opposing proposed cuts in AHRQ funding.
   
03/04/02 AACC submitted comments to the HHS Regulatory Reform Initiative regarding changes to the health care system
   
01/30/02 AACC wrote to Rep. Dave Camp (R-MI) endorsing HR 3278, the Medicare Cholesterol Screening Coverage Act of 2001.
   
01/28/02 AACC initiated a laboratory coalition letter to CMS supporting board- certification of PhD high complexity laboratory directors.
   
01/15/02 AACC submitted comments to CMS supporting board-certification of PhD high complexity laboratory directors.
   
01/15/02 AACC submitted comments to CMS supporting the agency’s new public consultation process for setting payment rates for new laboratory tests.